EPSILON HEALTHCARE ORD
Epsilon Pharma Inks Medicinal Cannabis Deal with Puro New Zealand for UK Market
Epsilon Pharma (ASX: EPN) inks $6m UK medicinal cannabis CDMO deal with Puro NZ; revenue starts this quarter, full run rate by mid-year, Europe expansion eyed.
Epsilon Healthcare partners with Valens to produce medicinal cannabis for global markets
Epsilon Healthcare (ASX: EPN) will make its Queensland-based production facility available to Canadian medicinal cannabis maker The Valens Company under a long-term partnership designed to boost Valens’ regional profile. The agreement will give Valens access to Epsilon’s manufacturing expertise and offer Valens the opportunity to further its international expansion to GMP (good manufacturing practice) markets […]
Epsilon Healthcare appoints cannabis industry expert to leadership team
Diversified global pharmaceuticals company Epsilon Healthcare (ASX: EPN) has appointed cannabis industry professional Edward Jones to the role of divisional manager (cannabis operations) responsible for the performance of its subsidiaries THC Pharma and Canndeo. Mr Jones has a leadership background spanning many senior roles within global pharmaceutical manufacturing and multi-national project environments. He has previously […]
Strategic review realises quarterly cost savings for Epsilon Healthcare
Diversified pharmaceuticals company Epsilon Healthcare (ASX: EPN), formerly THC Global Group, has posted its first quarterly report since finalising a major strategic review of its operations late last year. The company said it has realised the bulk of the cost savings implemented following the review and reported a further reduction in net cash used in […]